{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

Lexaria's Animal Study GLP-1-A26-1 has Begun Dosing on Schedule

June 23, 2026Potentially Valuable Novel Compositions Being Investigated Lexaria Also Receives Additional New Granted Patent KELOWNA, BRITISH COLUMBIA - June 23, 2026 (NEWMEDIAWIRE) - Lexaria Bioscience Corp. (Nasdaq: LEXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, provides the following update on Animal Study #1 (GLP-1-A26-1) that is evaluating a number of formulation enhancements using both DehydraTECH-semaglutide (“DHT-sema”) glucagon-like peptide-1 (“GLP-1”) compositions and DehydraTECH-CBD (“DHT-CBD”) compositions to explore the potential for additional improved performance as well as stake new intellectual property (“IP”) claims (the “Study”).


tZERO to Bring Archax $GOVY to US Institutional Investors Unlocking Tokenized Treasuries Access Through Regulated US Infrastructure

June 23, 2026Partnership Will Enable US Distribution of Archax’s Tokenized Short-Term Treasuries Product via tZERO’s SEC- and FINRA-Regulated Broker-Dealer Ecosystem NEW YORK, NY - June 23, 2026 (NEWMEDIAWIRE) - tZERO Group, Inc. , a leader in blockchain-based financial infrastructure, and Archax, the UK/EU-regulated digital asset platform, today announced that Archax’s $GOVY tokenized US Treasury Bill product will be available for distribution to US qualified purchasers through tZERO’s SEC-registered and FINRA-member broker-dealer and custodial infrastructure for tokenized assets later this year.


LataMed AI Expands Healthcare Industry Visibility Through Upcoming ES Salud Magazine Feature

June 23, 2026CARACAS, VENEZUELA - June 23, 2026 (NEWMEDIAWIRE) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that its Venezuelan operating affiliate, LataMed AI VE, will be featured in an interview in ES Salud Magazine, a healthcare-focused publication covering healthcare businesses, medical innovation, and developments within the healthcare sector.


Investors Overwhelmingly Favor Quarterly Earnings Reporting Vs. Semi-Annually, Survey Finds

June 23, 2026Issuers Receptive to Less Frequent Reporting, Respondents Suggest LOS ANGELES, CA - June 23, 2026 (NEWMEDIAWIRE) - Seventy-seven percent of investors say companies should continue reporting quarterly results, according to a survey conducted by PondelWilkinson, an investor relations and strategic public relations consultancy. By contrast, 18% of investors believe public companies should report results semi-annually, while 5% support semi-annual reporting supplemented by select key metrics in non-reporting quarters.


Wisdom Bridge Authors, LLC Launches to Bring Transformational English Books to 500 Million Spanish Speakers

June 23, 2026Two Founding Author Spots Remaining MIAMI, FL - June 23, 2026 (NEWMEDIAWIRE) - Wisdom Bridge Authors, LLC today announces its official launch as a full-service publishing and course creation company dedicated exclusively to bringing high-impact, transformational books to Spanish-speaking readers around the world. The company has already secured its first Founding Author and is now opening the two remaining spots, a unique opportunity for conscious leaders ready to share their wisdom across languages.


CTTC Expands Statewide Workforce Development Through New Leadership and Academic Partnerships

June 23, 2026LONG BEACH, CA - June 23, 2026 (NEWMEDIAWIRE) - The California Transit Training Consortium (CTTC) announced key leadership appointments and an expanded workforce development strategy designed to strengthen academic partnerships, broaden technical training opportunities, and support the evolving needs of California’s public transit industry. Since unveiling its refreshed brand identity in 2024, CTTC has grown its statewide presence and now serves 42 public transit agencies across California.


Sandoz to Host Capital Markets Day: Maximising Sandoz Value in Its Golden Decade for Biosimilars

June 22, 2026BASEL, SWITZERLAND - June 22, 2026 (NEWMEDIAWIRE) - Sandoz (SIX:SDZ / OTCQX:SDZNY), the global leader in affordable medicines, will host its 2026 capital markets day for investors and analysts: Tuesday, 8 September 13:30-17:00 UK time London Stock Exchange In-person and live webcast The formal part of the event, webcast live, will begin at 13:30. In-person attendance will be by invitation only on a first-come, first-served basis; invitations will be distributed in due course.


NAGRAVISION Launches NAGRA Venturi, Intelligence-Led Streaming Security for the AI EraTitle

June 22, 2026New Offer Nnifies NAGRAVISION's Streaming Security Capabilities Into a Single Intelligence-led Model, Turning Fragmented Piracy Data Into Prioritized, Decisive Action as Piracy Becomes Faster, Automated and Increasingly AI-driven CHESEAUX-SUR-LAUSANNE, SWITZERLAND and PHOENIX, AZ - June 22, 2026 (NEWMEDIAWIRE) - NAGRAVISION, a Kudelski Group (SIX:KUD. S) company and the world’s leading independent provider of content protection and media and entertainment solutions, today announced the launch of NAGRA Venturi, intelligence-led streaming security that helps service providers and rights holders detect threats, combat piracy, and safeguard revenue - faster and with greater precision.


cyan AG Adds FileWave as a New Partner for cyan Guard 360

June 22, 2026MUNICH, GERMANY - June 22, 2026 (NEWMEDIAWIRE) - cyan AG, a provider of intelligent cybersecurity solutions, continues to expand the distribution of its new security solution, cyan Guard 360, and has partnered with FileWave, an internationally established provider of unified endpoint management solutions. The integration of cyan Guard 360 underscores the solution’s technological maturity and its ease of scalability in complex IT environments.


Siltronic Returns to the MDAX

June 22, 2026MUNICH, GERMANY - June 22, 2026 (NEWMEDIAWIRE) - As of today, the Siltronic AG share has been readmitted to the MDAX stock index. This follows the positive development of its free-float market capitalization over the past few months.


VERAXA Biotech (VRXA) Showcases BiTAC Cancer Platforms Ahead of BIO International Convention

June 22, 2026LOS ANGELES, CA - June 22, 2026 (NEWMEDIAWIRE) - VERAXA Biotech (NASDAQ: VRXA) is highlighting partnering opportunities for its proprietary BiTAC(TM)-ADC and BiTAC-TCE technology platforms ahead of the BIO International Convention, taking place June 22-25 in San Diego. The company recently reported new proof-of-concept data supporting its BiTAC-ADC platform, which is designed to improve cancer treatment precision through tumor-restricted activation of therapeutic agents while minimizing off-target toxicity.


Does Drinking Juice, Soda During Childhood Increase the Risk of High Blood Pressure?

June 22, 2026Research Highlights: In a study that spanned 25 years, people who drank more sugary beverages and fruit juice beginning in childhood had a higher risk of developing high blood pressure than those drinking less. Substituting one serving per day of sugary beverages with whole fruit, milk or water was associated with a lower risk of high blood pressure.


VERAXA Biotech (VRXA) Reports Proof-of-Concept Data for BiTAC-ADC Cancer Therapy Platform

June 19, 2026LOS ANGELES, CA - June 19, 2026 (NEWMEDIAWIRE) - VERAXA Biotech (NASDAQ: VRXA) announced new in vitro proof-of-concept data supporting its novel BiTAC(TM)-ADC technology platform, which is designed to improve precision in cancer treatment through tumor-restricted activation of therapeutic agents. The company reported that BiTAC-ADCs demonstrated the ability to distinguish between breast cancer and healthy cells and achieved dose-dependent killing of 3D tumor cell spheroids while minimizing toxicity through the use of separately delivered, systemically inactive precursor components.